High serum CD44 levels may help identify docetaxel-resistant patients and may thereby help optimize clinical decision-making regarding type and timing of therapy for metastatic CRPC patients patients.
[Journal of Cellular and Molecular Medicine]
Sorry, but the selected Zotpress account can't be found.